Malignant hyperthermia susceptibility diagnosed with a family-specific ryanodine receptor gene type 1 mutation

Journal of Anesthesia

Volumn 22, Issue 1, 2008, Pages 70-73

  Tanabe, Takahiro ^a   Fukusaki, Makoto ^a   Terao, Yoshiaki ^a   Yamashita, Kazunori ^a   Sumikawa, Koji ^b   Mukaida, Keiko ^c   Ibarra, Carlos A ^d   Nishino, Ichizo ^d  

^a NAGASAKI ROSAI HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Hiroshima Prefectural Rehabilitation Center   (Japan)

^d NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Calcium induced calcium release; Genetic diagnosis of malignant hyperthermia; Malignant hyperthermia; Ryanodine receptor gene type 1

Indexed keywords

CALCIUM; DANTROLENE; FENTANYL; GENOMIC DNA; PROPOFOL; RYANODINE RECEPTOR 1; VECURONIUM;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DNA EXTRACTION; EXON; FAMILY; FATHER; GENE MUTATION; GENETIC SUSCEPTIBILITY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INHALATION ANESTHESIA; INTRAVENOUS ANESTHESIA; INTRON; LEG FRACTURE; MALE; MALIGNANT HYPERTHERMIA; MUSCLE BIOPSY; POLYMERASE CHAIN REACTION;

ADULT; CALCIUM; FAMILY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; JAPAN; MALE; MALIGNANT HYPERTHERMIA; MUTATION; PEDIGREE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 40349085760     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-007-0575-1     Document Type: Article

References (15)

1. Nelson TE (2002) Malignant hyperthermia A pharmacogenetic disease of Ca++ regulating proteins. Curr Mol Med 2:347-369
2. Yuge O, Mukaida K (2002) Malignant hyperthermia. Nippon Rinsho (Jpn J Clin Med) 60 (Suppl 1):635-642
3. Larach MG (1989) Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 69:511-515
4. Ording H, for the European Malignant Hyperthermia Group (1997) In vitro contracture test for the diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH, and unrelated low-risk subjects. Acta Anaesthesiol Scand 41:955-966
5. Endo M, Yagi S, Ishizuka T, Horiuti K, Koga Y, Amaha K (1983) Changes in the Ca-induced Ca release mechanism in the sarcoplasmic reticulum of the muscle from a patient with malignant hyperthermia. Biomed Res 4:83-92
6. Kikuchi H, Matsui K, Morio M (1987) Diagnosis of malignant hyperthermia in Japan by the skinned fiber test. In: Britt B (ed) Malignant hyperthermia. Martinus Nijhoff, Boston, pp 279-294
7. Fill M, Copello JA (2002) Ryanodine receptor calcium release channels. Physiol Rev 82:893-922
8. Endo M, Yagi S, Ishizuka T, Horiuti K, Koga Y, Amaha K (1983) Changes in the Ca-induced Ca release mechanism in the sarcoplasmic reticulum of the muscle from a patient with malignant hyperthermia. Biomed Res 4:83-92
9. Oku S, Mukaida K, Nosaka S, Sai Y, Maehara Y, Yuge O (2000) Comparison of the in vitro caffeine-halothane contracture test with the Ca-induced Ca release rate test in patients suspected of having malignant hyperthermia susceptibility. J Anesth 14:6-13
10. Sambrook J, Russell DW (2001) Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, New York, pp 6.4-6.12
11. Ibarra CA, Wu S, Murayama K, Minami N, Ichihara Y, Kikuchi H, Noguchi S, Hayashi YK, Ochiai R, Nishino I (2006) Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology 104:1146-1154
12. Urwyler A, Deufel T, McCarthy T, West S (2001) Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 86:283-287
13. Sei Y, Sambuughin N, Muldoon S (2003) Malignant Hyperthermia Genetic Testing in North America Working Group Meeting. Anesthesiology 100:464-465
14. Treves S, Anderson AA, Ducreux S, Divet A, Bleunven C, Grasso C, Paesante S, Zorzato F (2005) Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscul Disord 15:577-587
15. Oyamada H, Oguchi K, Saitoh N, Yamazawa T, Hirose K, Kawana Y, Wakatsuki K, Oguchi K, Tagami M, Hanaoka K, Endo M, Iino M (2002) Novel mutations in C-terminal channel region of the ryanodine receptor in malignant hyperthermia patients. Jpn J Pharmacol 88:159-166